CS156406B2 - - Google Patents

Info

Publication number
CS156406B2
CS156406B2 CS155667A CS155667A CS156406B2 CS 156406 B2 CS156406 B2 CS 156406B2 CS 155667 A CS155667 A CS 155667A CS 155667 A CS155667 A CS 155667A CS 156406 B2 CS156406 B2 CS 156406B2
Authority
CS
Czechoslovakia
Application number
CS155667A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS156406B2 publication Critical patent/CS156406B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS155667A 1966-03-04 1967-03-02 CS156406B2 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH315466A CH472404A (de) 1966-03-04 1966-03-04 Verfahren zur Herstellung neuer Indolderivate

Publications (1)

Publication Number Publication Date
CS156406B2 true CS156406B2 (cs) 1974-07-24

Family

ID=4249777

Family Applications (1)

Application Number Title Priority Date Filing Date
CS155667A CS156406B2 (cs) 1966-03-04 1967-03-02

Country Status (7)

Country Link
AT (1) AT266112B (cs)
CH (1) CH472404A (cs)
CS (1) CS156406B2 (cs)
DK (1) DK121168B (cs)
ES (1) ES337457A1 (cs)
FI (1) FI47365C (cs)
SE (1) SE308720B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1357A1 (fr) * 1979-12-07 1981-08-10 Hoffmann La Roche Derives de 2,3-indoledione
RS20050106A (en) 2002-08-19 2007-11-15 Pfizer Products Inc., Combination therapy for hyperproliferative diseases
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
AT266112B (de) 1968-11-11
SE308720B (cs) 1969-02-24
FI47365B (cs) 1973-07-31
ES337457A1 (es) 1968-03-01
CH472404A (de) 1969-05-15
DK121168B (da) 1971-09-20
FI47365C (fi) 1973-11-12

Similar Documents

Publication Publication Date Title
AU5917865A (cs)
AU424443B2 (cs)
AU428063B2 (cs)
AU415165B1 (cs)
AU414526B2 (cs)
AU421822B2 (cs)
AU433222B2 (cs)
AU417216B2 (cs)
AU5895065A (cs)
AU6703465A (cs)
AU218666A (cs)
AU1144366A (cs)
AU1111066A (cs)
AU612166A (cs)
BE694387A (cs)
AU414093B2 (cs)
AU855865A (cs)
AU92366A (cs)
BE284991A (cs)
BE447356A (cs)
AU433620A (cs)
BE475118A (cs)
BE529218A (cs)
BE597652A (cs)
BE618801A (cs)